| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 332,298 | 332,069 | 339,520 | 353,512 | | Cost of Revenue | 121,912 | 126,964 | 129,259 | 128,232 | | | Gross Profit | 210,386 | 205,105 | 210,261 | 225,280 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 153,999 | 151,730 | 158,356 | 160,449 | | Non Recurring | 1,838 | 292 | 24,723 | 2,011 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 54,549 | 53,083 | 27,182 | 62,820 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 169 | 208 | 10,191 | 256 | | Earnings Before Interest And Taxes | 54,718 | 53,291 | 37,373 | 63,076 | | Interest Expense | 11,495 | 11,627 | 12,420 | 12,548 | | Income Before Tax | 43,223 | 41,664 | 24,953 | 50,528 | | Income Tax Expense | 14,667 | 13,888 | 12,449 | 18,350 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 28,556 | 27,776 | 12,504 | 32,178 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (4,238) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,556 | 27,776 | 12,504 | 27,940 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $28,556 | $27,776 | $12,504 | $27,940 |
|
0.11% Nasdaq 0.00%
Income Statement
